Evolus (EOLS) Return on Equity [ROE] (2018 - 2024)
Evolus (EOLS) posted Return on Equity [ROE] of -883.63% for Q4 2024, down 443.54 percentage points from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Return on Equity [ROE] (2018 - 2024) Analysis & Trends
For FY2022, Evolus' Return on Equity [ROE] came in at -148.27%, up 901.52 percentage points from FY2021.
- Annual Return on Equity [ROE] shows a four-year change of +911.95 percentage points (FY2018 to FY2022).
- In prior years, Evolus' Return on Equity [ROE] was -1049.79% in FY2021 (+3966.77 pp), -5016.56% in FY2020 (-4906.65 pp), -109.90% in FY2019 (+950.32 pp) and -1060.22% in FY2018.
- The Q4 2024 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q2 2018.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2020, with a gain of 132.34 percentage points; the weakest was Q1 2023, with a drop of 471.43 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Evolus | 450.43 Mn | 259.94 Mn | 50.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -892.01% |
| Sep 30, 2024 | -440.75% |
| Jun 30, 2024 | -282.58% |
| Mar 31, 2023 | -565.98% |
| Dec 31, 2022 | -313.29% |
| Sep 30, 2022 | -209.76% |
| Jun 30, 2022 | -138.02% |
| Mar 31, 2022 | -94.97% |
| Dec 31, 2021 | -52.22% |
| Sep 30, 2021 | -136.91% |
| Jun 30, 2021 | -203.01% |
| Sep 30, 2020 | -169.87% |
| Jun 30, 2020 | -155.12% |
| Mar 31, 2020 | -138.76% |
| Dec 31, 2019 | -186.59% |
| Sep 30, 2019 | -302.11% |
| Jun 30, 2019 | -124.89% |
| Mar 31, 2019 | -64.72% |
| Dec 31, 2018 | -52.26% |
| Sep 30, 2018 | -45.11% |
API Access
Evolus Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();